Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 881

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 881
---
|:---------|-------:|:--|:------------|-------:|:--|-----------:|
| Series A preferred stock | ​ | $         | 0.001 |   |  9,499,999 |   |    9,499,999 | ​ | $        |  9,327 | ​ | $           |  9,500 |   |  9,499,999 |
| Series B preferred stock | ​ |           | 0.001 |   | 20,223,541 |   |   20,055,539 | ​ |          | 76,176 | ​ |             | 76,402 |   | 20,055,539 |
| ​                        | ​ | ​         |     ​ |   | 29,723,540 |   |   29,555,538 | ​ | $        | 85,503 | ​ | $           | 85,902 |   | 29,555,538 |

The key terms of Preferred Stock are as follows: Dividends The Company shall not declare, pay or set aside any dividends on shares or any other class or series of capital stock (other than dividends on shares of the Company’s common stock payable in shares of common stock) unless first the holders of Series B preferred stock shall first receive, or simultaneously receive, a dividend on each outstanding preferred stock, and second, the holders of the Series A preferred stock shall next receive, or simultaneously receive a dividend on each outstanding preferred stock. If the Company declares, pays or sets aside, on the same date, a dividend on shares of more than one class or series of capital stock of the Company, the dividend payable to the holders of Preferred Stock shall be calculated based upon the dividend on the class or series of capital stock that would result in the highest dividend. There have been no dividends declared by the Company’s board of directors, or the Board, as of September 30, 2024 and December 31, 2023.

F-125

<div align='center'>TVARDI THERAPEUTICS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)</div>

Voting Rights

The holder of each share of Series A and Series B preferred stock shall have the right to one vote for each share of common stock into which such Series A and Series B preferred stock could then be converted.

Right to Elect Directors

Holders of Series A